CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Earnings (Loss)	Noncontrolling Interest (NCI)	Total
Beginning balance at Dec. 30, 2023	$ 61,621	$ 354,702	$ 2,582,332	$ 1,106	$ 30,429	$ 3,030,190
Increase (Decrease) in Stockholders' Equity
Net earnings (loss)			120,791		622	121,413
Foreign currency translation adjustment				(1,419)	616	(803)
Unrealized gain (loss) on debt securities				6		6
Distributions to NCI					(3,331)	(3,331)
Cash dividends			(20,411)			(20,411)
Issuance of shares under employee stock purchase plan	6	648				654
Issuance of shares under stock grant programs	369	5,829				6,198
Issuance of shares under deferred compensation plans	77	(77)
Repurchase of shares	(319)	(17,686)	(18,631)			(36,636)
Expense associated with share-based compensation arrangements		11,194				11,194
Accrued expense under deferred compensation plans		7,621				7,621
Ending balance at Mar. 30, 2024	61,754	362,231	2,664,081	(307)	28,336	3,116,095
Increase (Decrease) in Stockholders' Equity
Net earnings (loss)			125,930		652	126,582
Foreign currency translation adjustment				(5,594)	(2,220)	(7,814)
Unrealized gain (loss) on debt securities				(64)		(64)
Other		(607)				(607)
Distributions to NCI					(6,069)	(6,069)
Cash dividends			(20,249)			(20,249)
Issuance of shares under employee stock purchase plan	9	807				816
Issuance of shares under stock grant programs	29	1	5			35
Issuance of shares under deferred compensation plans	10	(10)
Repurchase of shares	(883)		(99,681)			(100,564)
Expense associated with share-based compensation arrangements		7,954				7,954
Accrued expense under deferred compensation plans		1,395				1,395
Ending balance at Jun. 29, 2024	60,919	371,771	2,670,086	(5,965)	20,699	3,117,510
Beginning balance at Dec. 28, 2024	60,724	403,379	2,775,280	(15,311)	20,553	3,244,625
Increase (Decrease) in Stockholders' Equity
Net earnings (loss)			78,753		853	79,606
Foreign currency translation adjustment				2,744	(31)	2,713
Unrealized gain (loss) on debt securities				470		470
Other		(355)				(355)
Cash dividends			(21,322)			(21,322)
Issuance of shares under employee stock purchase plan	7	643				650
Issuance of shares under stock grant programs	232	3,055	101			3,388
Issuance of shares under deferred compensation plans	81	(81)
Repurchase of shares	(649)	(9,460)	(59,991)			(70,100)
Expense associated with share-based compensation arrangements		11,493				11,493
Accrued expense under deferred compensation plans		7,888				7,888
Ending balance at Mar. 29, 2025	60,395	416,562	2,772,821	(12,097)	21,375	3,259,056
Increase (Decrease) in Stockholders' Equity
Net earnings (loss)			100,734		376	101,110
Foreign currency translation adjustment				10,239	1,615	11,854
Unrealized gain (loss) on debt securities				(118)		(118)
Other		(1,818)				(1,818)
Distributions to NCI					(285)	(285)
Cash dividends			(20,656)			(20,656)
Issuance of shares under employee stock purchase plan	8	636				644
Issuance of shares under stock grant programs	27	17	1			45
Issuance of shares under deferred compensation plans	10	(10)
Repurchase of shares	(1,874)	(13)	(189,506)			(191,393)
Expense associated with share-based compensation arrangements		8,755				8,755
Accrued expense under deferred compensation plans		1,269				1,269
Ending balance at Jun. 28, 2025	$ 58,566	$ 425,398	$ 2,663,394	$ (1,976)	$ 23,081	$ 3,168,463

UFP INDUSTRIES INC 10-Q